Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders

[(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders

US Patent 6245799 · Granted Jun 12, 2001

Estimated economic value: $414,307,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists2010
N-substituted-azacyclylamines as histamine-3 antagonists2010
Substituted 3-cyanopyridines as protein kinase inhibitors2010
Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor2010
Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 2010
Dibenzo chromene derivatives and their use as ERβ selective ligands2010
Phenyl quinolines and their use as estrogenic agents2009
Azolylacylguanidines as β-secretase inhibitors2009
Antidepressant piperidine derivatives of heterocyclefused benzodioxans2009
Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 2007
Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agen2007
Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use2007